Zydus Lifesciences gets USFDA nod for generic product
Zydus Lifesciences Ltd on Monday said it has received final approval from the US health regulator to market its generic version of Cyanocobalamin injection which is used to treat and prevent vitamin B12 deficiency caused by pernicious anemia. The approval granted by the US Food and Drug Administration (USFDA) is for Cyanocobalamin injection in strengths…Continue Reading

